French Pharmaceuticals & Biotech Potentially Undervalued Companies

Sanofi

Market Cap: €98.1b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Oncodesign Société Anonyme

Market Cap: €99.4m

Oncodesign Société Anonyme, a biopharmaceutical company, conducts research and development work on new therapeutic and diagnostic tools with pharmaceutical firms, biotech companies, public research institutions, and investment groups.

Oncodesign Precision Medicine Société anonyme

Market Cap: €7.2m

A biopharmaceutical company, engages in the precision medicine business.

Valneva

Market Cap: €635.7m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

Cellectis

Market Cap: €296.9m

A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.

Vetoquinol

Market Cap: €916.5m

A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region.

Eurofins Scientific

Market Cap: €10.3b

Provides various analytical testing and laboratory services worldwide.

Adocia

Market Cap: €124.0m

A clinical-stage biotechnology company, researches and develops therapeutic solutions for diabetes and obesity.

Novacyt

Market Cap: €32.0m

Develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors.

OSE Immunotherapeutics

Market Cap: €109.0m

A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.

Boiron

Market Cap: €519.1m

Manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally.

Ipsen

Market Cap: €10.0b

Operates as a biopharmaceutical company worldwide.

Advicenne

Market Cap: €25.5m

A specialty pharmaceutical company, develops, commercializes, and markets treatments for rare renal diseases in France and internationally.

Euroapi

Market Cap: €295.2m

Develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally.

Virbac

Market Cap: €2.8b

Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific.